Contineum Therapeutics In... (CTNM)
12.89
0.12 (0.94%)
At close: Jan 15, 2025, 3:59 PM
12.96
0.54%
After-hours Jan 15, 2025, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 |
| Net Income | 22.72M | -24.25M | -29.00M |
| Depreciation & Amortization | 195.00K | 329.00K | 325.00K |
| Stock-Based Compensation | 2.22M | 1.93M | 1.75M |
| Other Working Capital | -1.02M | -1.04M | 218.00K |
| Other Non-Cash Items | -4.76M | 5.96M | 164.00K |
| Deferred Income Tax | n/a | n/a | n/a |
| Change in Working Capital | -1.02M | -1.27M | 108.00K |
| Operating Cash Flow | 19.35M | -20.12M | -26.27M |
| Capital Expenditures | -414.00K | -118.00K | -168.00K |
| Acquisitions | n/a | n/a | n/a |
| Purchase of Investments | -141.87M | -64.70M | -66.78M |
| Sales Maturities Of Investments | 76.71M | 87.12M | 1.98M |
| Other Investing Acitivies | n/a | 22.42M | -64.80M |
| Investing Cash Flow | -65.57M | 22.30M | -64.97M |
| Debt Repayment | -3.75M | -1.25M | n/a |
| Common Stock Repurchased | -28.00K | -4.00K | n/a |
| Dividend Paid | n/a | n/a | n/a |
| Other Financial Acitivies | 59.95M | 15.00K | 79.84M |
| Financial Cash Flow | 56.18M | -1.24M | 79.84M |
| Net Cash Flow | 9.96M | 939.00K | -11.39M |
| Free Cash Flow | 18.93M | -20.24M | -26.43M |